Related Experiment Video
Updated: Jun 18, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Reciprocal interactions between lncRNAs and MYC in colorectal cancer: partners in crime
Zhen Lei1, Zhipu Zhu1, Zhihui Yao1
1Translational Research Institute, People's Hospital of Zhengzhou University, Academy of Medical Science, Henan International Joint Laboratory of Non-coding RNA and Metabolism in Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, 450003, China.
Abstract:
Proto-oncogenic MYC is frequently dysregulated in colorectal cancer (CRC). In the past decades, long noncoding RNAs (lncRNAs) have emerged as important regulators in cancers, acting as scaffolds, molecular decoys, post-transcriptional regulators, and others. Interestingly, lncRNAs are able to control MYC expression both at transcriptional and post-transcriptional levels. It is suggested that the reciprocal interaction of MYC and lncRNAs often occurs in CRC. MYC can affect the cell fate by promoting or inhibiting the transcription of some lncRNAs. At the same time, some lncRNAs can also affect MYC expression or transcriptional activity, and in turn decide the cell fate. In this review we summarized the current knowledge about the MYC and lncRNA axis, focusing on its mutual regulation, roles in CRC, and proposed potential therapeutic prospects for CRC treatment.
Insights
This review explores the MYC and long noncoding RNA (lncRNA) axis in colorectal cancer (CRC). It details their reciprocal regulation and roles, highlighting potential therapeutic strategies for CRC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Proto-oncogenic MYC is frequently dysregulated in colorectal cancer (CRC).
- Long noncoding RNAs (lncRNAs) are critical regulators in cancer development.
- A complex interplay exists between MYC and lncRNAs in various cancers, including CRC.
Purpose of the Study:
- To review the current understanding of the MYC and lncRNA axis in CRC.
- To elucidate the mutual regulatory mechanisms between MYC and lncRNAs.
- To explore the therapeutic potential of targeting this axis in CRC.
Main Methods:
- Literature review of studies investigating MYC and lncRNA interactions in CRC.
- Analysis of the roles of lncRNAs in regulating MYC expression and activity.
- Examination of MYC's influence on lncRNA transcription and function.
Main Results:
- MYC and lncRNAs exhibit reciprocal regulatory interactions in CRC.
- lncRNAs modulate MYC expression at both transcriptional and post-transcriptional levels.
- MYC influences lncRNA transcription, affecting cell fate decisions in CRC.
Conclusions:
- The MYC-lncRNA axis plays a significant role in CRC pathogenesis.
- Targeting the MYC-lncRNA interaction presents a promising therapeutic avenue for CRC.
- Further research into this axis could lead to novel CRC treatment strategies.
More Related Videos
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
Non-LTR Retrotransposons